Cellosaurus HT-29 BR300 (CVCL_DH90)

Cell line name HT-29 BR300
Synonyms HT29 BR300; BR300
Accession CVCL_DH90
Resource Identification Initiative To cite this cell line use: HT-29 BR300 (RRID:CVCL_DH90)
Comments Selected for resistance to: ChEBI; CHEBI:52717; Bortezomib (Velcade).
Sequence variations Heterozygous for PC p.Glu853Ter (c.2557G>T) and p.Thr1556fs*3 (c.4666_4667insA) (from parent cell line).
Heterozygous for BRAF p.Val600Glu (c.1799T>A) (from parent cell line).
Heterozygous for PIK3CA p.Pro449Thr (c.1345C>A) (from parent cell line).
Homozygous for SMAD4 p.Gln311Ter (c.931C>T) (from parent cell line).
Homozygous for TP53 p.Arg273His (c.818G>A) (from parent cell line).
Disease Rectosigmoid adenocarcinoma (NCIt: C43584)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_0320 (HT-29)
Sex of cell Female
Age at sampling 44Y
Category Cancer cell line
Cross-references
Gene expression databases GEO; GSM736970
Other Wikidata; Q54896511